These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18602747)

  • 1. beta-Catenin/TCF pathway upregulates STAT3 expression in human esophageal squamous cell carcinoma.
    Yan S; Zhou C; Zhang W; Zhang G; Zhao X; Yang S; Wang Y; Lu N; Zhu H; Xu N
    Cancer Lett; 2008 Nov; 271(1):85-97. PubMed ID: 18602747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of EB1 in human esophageal squamous cell carcinoma (ESCC) may promote cellular growth by activating beta-catenin/TCF pathway.
    Wang Y; Zhou X; Zhu H; Liu S; Zhou C; Zhang G; Xue L; Lu N; Quan L; Bai J; Zhan Q; Xu N
    Oncogene; 2005 Oct; 24(44):6637-45. PubMed ID: 16007168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription factor Egr1 acts as an upstream regulator of beta-catenin signalling through up-regulation of TCF4 and p300 expression during trans-differentiation of endometrial carcinoma cells.
    Saegusa M; Hashimura M; Kuwata T; Hamano M; Watanabe J; Kawaguchi M; Okayasu I
    J Pathol; 2008 Dec; 216(4):521-32. PubMed ID: 18798221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
    Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
    Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas.
    Sareddy GR; Panigrahi M; Challa S; Mahadevan A; Babu PP
    Neurochem Int; 2009 Sep; 55(5):307-17. PubMed ID: 19576519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FRAT1 overexpression leads to aberrant activation of beta-catenin/TCF pathway in esophageal squamous cell carcinoma.
    Wang Y; Liu S; Zhu H; Zhang W; Zhang G; Zhou X; Zhou C; Quan L; Bai J; Xue L; Lu N; Xu N
    Int J Cancer; 2008 Aug; 123(3):561-8. PubMed ID: 18498136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer.
    Takahashi M; Nakamura Y; Obama K; Furukawa Y
    Int J Oncol; 2005 Dec; 27(6):1483-7. PubMed ID: 16273202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Constitutive activation of signal transducers and activators of transcription 3 and expression of its target gene products in human ESCC cell line].
    Wang XH; Li SS; Yan AH; Lu CX; Guo YP
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Apr; 26(4):441-4. PubMed ID: 16624747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of axin downregulates TCF-4 and inhibits the development of lung cancer.
    Xu HT; Wei Q; Liu Y; Yang LH; Dai SD; Han Y; Yu JH; Liu N; Wang EH
    Ann Surg Oncol; 2007 Nov; 14(11):3251-9. PubMed ID: 17768662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of human pituitary tumor transforming gene (hPTTG), is regulated by beta-catenin /TCF pathway in human esophageal squamous cell carcinoma.
    Zhou C; Liu S; Zhou X; Xue L; Quan L; Lu N; Zhang G; Bai J; Wang Y; Liu Z; Zhan Q; Zhu H; Xu N
    Int J Cancer; 2005 Mar; 113(6):891-8. PubMed ID: 15514942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinoma.
    Du XL; Yang H; Liu SG; Luo ML; Hao JJ; Zhang Y; Lin DC; Xu X; Cai Y; Zhan QM; Wang MR
    Oncogene; 2009 Oct; 28(42):3714-22. PubMed ID: 19684620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Securin (hPTTG1) expression is regulated by beta-catenin/TCF in human colorectal carcinoma.
    Hlubek F; Pfeiffer S; Budczies J; Spaderna S; Jung A; Kirchner T; Brabletz T
    Br J Cancer; 2006 Jun; 94(11):1672-7. PubMed ID: 16705313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant changes of Wnt2/beta-catenin signaling pathway induced by sodium nitroprusside in human esophageal squamous cell carcinoma cell lines.
    Wang W; Xue L; Liu H; Wang P; Xu P; Cai Y
    Cancer Invest; 2010 Mar; 28(3):230-41. PubMed ID: 19857041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transducers and activators of transcription 3 activation is involved in nuclear accumulation of beta-catenin in colorectal cancer.
    Kawada M; Seno H; Uenoyama Y; Sawabu T; Kanda N; Fukui H; Shimahara Y; Chiba T
    Cancer Res; 2006 Mar; 66(6):2913-7. PubMed ID: 16540637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta-Catenin/TCF pathway plays a vital role in selenium induced-growth inhibition and apoptosis in esophageal squamous cell carcinoma (ESCC) cells.
    Zhang W; Yan S; Liu M; Zhang G; Yang S; He S; Bai J; Quan L; Zhu H; Dong Y; Xu N
    Cancer Lett; 2010 Oct; 296(1):113-22. PubMed ID: 20457486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression and clinical significance of COX-2, p-Stat3, and p-Stat5 in esophageal carcinoma].
    Liu JR; Wang Y; Zuo LF; Li FL; Wang Y; Liu JL
    Ai Zheng; 2007 May; 26(5):458-62. PubMed ID: 17672932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibitory mechanism of curcumin and its derivative against beta-catenin/Tcf signaling.
    Park CH; Hahm ER; Park S; Kim HK; Yang CH
    FEBS Lett; 2005 May; 579(13):2965-71. PubMed ID: 15893313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-catenin control of T-cell transcription factor 4 (Tcf4) importation from the cytoplasm to the nucleus contributes to Tcf4-mediated transcription in 293 cells.
    Hsu HT; Liu PC; Ku SY; Jung KC; Hong YR; Kao C; Wang C
    Biochem Biophys Res Commun; 2006 May; 343(3):893-8. PubMed ID: 16564030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through beta-catenin-T-cell factor/Lef signaling.
    Deng YZ; Chen PP; Wang Y; Yin D; Koeffler HP; Li B; Tong XJ; Xie D
    J Biol Chem; 2007 Dec; 282(50):36571-81. PubMed ID: 17951630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis.
    Ito K; Lim AC; Salto-Tellez M; Motoda L; Osato M; Chuang LS; Lee CW; Voon DC; Koo JK; Wang H; Fukamachi H; Ito Y
    Cancer Cell; 2008 Sep; 14(3):226-37. PubMed ID: 18772112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.